Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > If they moved VXL up 400%..Imagine

<< Previous

Bullboard Posts

Next >>

Comment by shareswapperon Jan 02, 2021 11:58pm

167 Views

Post# 32210775

RE:RE:If they moved VXL up 400%..Imagine

Kids - quit spamming, this is the ICO board. We don't need anyone considering any other trade and missing out on what is obviously a BIG BULL RUN opportunity with ICO. Go private message each other and keep this discussion to ICO and the BLOCKBUSTER potential of Oral Amp B!!!

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing